Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer

被引:4
|
作者
Zhao, Hanqing [1 ]
Huang, Ying [1 ]
Tong, Guoshun [1 ]
Wu, Wei [1 ]
Ren, Yangwu [1 ]
机构
[1] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110122, Peoples R China
基金
中国国家自然科学基金;
关键词
oxidative stress; anoikis; NSCLC; TME; immune landscape; stemness; MECHANISMS;
D O I
10.3390/ijms242216188
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to identify a kind of prognostic signature based on oxidative stress- and anoikis-related genes (OARGs) for predicting the prognosis and immune landscape of NSCLC. Initially, We identified 47 differentially expressed OARGs that primarily regulate oxidative stress and epithelial cell infiltration through the PI3K-Akt pathway. Subsequently, 10 OARGs related to prognosis determined two potential clusters. A cluster was associated with a shorter survival level, lower immune infiltration, higher stemness index and tumor mutation burden. Next, The best risk score model constructed by prognostic OARGs was the Random Survival Forest model, and it included SLC2A1, LDHA and PLAU. The high-risk group was associated with cluster A and poor prognosis, with a higher tumor mutation burden, stemness index and proportion of M0-type macrophages, and a lower immune checkpoint expression level, immune function score and IPS score. The calibration curve and decision-making curve showed that the risk score combined with clinical pathological characteristics could be used to construct a nomogram for guiding the clinical treatment strategies. Finally, We found that all three hub genes were highly expressed in tumor tissues, and LDHA expression was mainly regulated by has-miR-338-3p, has-miR-330-5p and has-miR-34c-5p. Altogether, We constructed an OARG-related prognostic signature to reveal potential relationships between the signature and clinical characteristics, TME, stemness, tumor mutational burden, drug sensitivity and immune landscape in NSCLC patients.
引用
收藏
页数:25
相关论文
共 50 条
  • [41] Genomic and Immune Landscape of Non-Small Cell Lung Cancer Brain Metastases
    Liu, Manlu
    Jagodinsky, Justin C.
    Callahan, S. Carson
    Minne, Rachel L.
    Johnson, D. Bryan
    Tomlins, Scott A.
    Iyer, Gopal
    Baschnagel, Andrew M.
    JCO PRECISION ONCOLOGY, 2025, 9
  • [42] PKCη Is a Novel Prognostic Marker in Non-small Cell Lung Cancer
    Krasnitsky, Ella
    Baumfeld, Yael
    Freedman, Janna
    Sion-Vardy, Netta
    Ariad, Samuel
    Novack, Victor
    Livneh, Etta
    ANTICANCER RESEARCH, 2012, 32 (04) : 1507 - 1513
  • [43] Identification of a predictive circulating immunological signature of response to immune checkpoint inhibitors in non-small cell lung cancer
    Khatir, Wassila
    Humbert, Olivier
    Neels, Jaap
    Berland, Lea
    Benzaquen, Jonathan
    Rivera, Fabian Andres Gallardo
    Allegra, Maryline
    Salah, Myriam
    Tanga, Virginie
    Bordone, Olivier
    Fayada, Julien
    Lespinet-Fabre, Virginie
    Long-Mira, Elodie
    Lassalle, Sandra
    Brest, Patrick
    Vouret, Valerie
    Maniel, Charlotte
    Boutros, Jacques
    Heeke, Simon
    Hofman, Veronique
    Marquette, Charles-Hugo
    Hofman, Paul
    Ilie, Marius
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer
    Xu, Fei
    Cui, Wen-qiang
    Liu, Cun
    Feng, Fubin
    Liu, Ruijuan
    Zhang, Jingtao
    Sun, Chang-gang
    FEBS OPEN BIO, 2023, 13 (01): : 72 - 88
  • [45] Prognostic Immune Markers in Non-Small Cell Lung Cancer-Letter
    Pandey, Janardan P.
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7835 - 7835
  • [46] Prognostic Immune Markers in Non-Small Cell Lung Cancer-Response
    Suzuki, Kei
    Adusumilli, Prasad S.
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7836 - 7836
  • [47] Integrative Analysis for Identification of Therapeutic Targets and Prognostic Signatures in Non-Small Cell Lung Cancer
    Erkin, Ozgur Cem
    Comertpay, Betul
    Gov, Esra
    BIOINFORMATICS AND BIOLOGY INSIGHTS, 2022, 16
  • [48] Integrative Analysis for Identification of Therapeutic Targets and Prognostic Signatures in Non-Small Cell Lung Cancer
    Erkin, Ozgur Cem
    Comertpay, Betul
    Gov, Esra
    BIOINFORMATICS AND BIOLOGY INSIGHTS, 2022, 16
  • [49] Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment
    Zhou, Jiao
    Shi, Shan
    Qiu, Yeqing
    Jin, Zhongwen
    Yu, Wenyan
    Xie, Rongzhi
    Zhang, Hongyu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [50] Identification of novel targets for radiosensitisation of non-small cell lung cancer by secretome analysis
    Sharma, A.
    Bender, S.
    Riesterer, O.
    Broggini-Tenzer, A.
    Pruschy, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 67 - 67